Author:
Harris S M,Mistry P,Freathy C,Brown J L,Charlton P A
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Allegra CJ, Grem JL (1997) Antimetabolites. In Cancer: Priniciples and Practice of Oncology, DeVita VT, Hellman S, Rosenberg SA (eds) 5th edn, pp 432–452. Philadelphia: Lippincott-Raven
2. Cao S, Durrani FA, Rustum YM (2004) Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumour xenografts. Clin Cancer Res 10: 2561–2569
3. Chou T, Talalay P (1984) Quantitative analysis of dose–effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27–55
4. Cree IA, Di Nicolantonio F, Neale MH, Charlton PA (2001) Ex vivo activity of two novel dual topoisomerase I and II inhibitors XR5944 and XR11576 against solid tumors. Clin Cancer Res 7(Suppl): 3746
5. Cummings J, Boyd G, Ethell BT, Macpherson JS, Burchell B, Smyth JF, Jodrell DI (2002) Enhanced clearance of topoisomerase I inhibitors from human colon cancer cells by glucuronidation. Biochem Pharmacol 63: 607–613
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献